Niagen Bioscience (NASDAQ:NAGE – Get Free Report) and Betterware de Mexico SAPI de C (NYSE:BWMX – Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Niagen Bioscience and Betterware de Mexico SAPI de C, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Niagen Bioscience | 0 | 1 | 3 | 1 | 3.00 |
| Betterware de Mexico SAPI de C | 1 | 0 | 1 | 1 | 2.67 |
Niagen Bioscience currently has a consensus price target of $10.00, suggesting a potential upside of 377.33%. Given Niagen Bioscience’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Niagen Bioscience is more favorable than Betterware de Mexico SAPI de C.
Valuation and Earnings
This table compares Niagen Bioscience and Betterware de Mexico SAPI de C”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Niagen Bioscience | $129.42 million | 1.29 | $17.38 million | $0.18 | 11.64 |
| Betterware de Mexico SAPI de C | $744.00 million | 0.87 | $55.37 million | $1.95 | 8.43 |
Betterware de Mexico SAPI de C has higher revenue and earnings than Niagen Bioscience. Betterware de Mexico SAPI de C is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
15.4% of Niagen Bioscience shares are owned by institutional investors. Comparatively, 12.7% of Betterware de Mexico SAPI de C shares are owned by institutional investors. 10.0% of Niagen Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Niagen Bioscience and Betterware de Mexico SAPI de C’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Niagen Bioscience | 8.37% | 10.26% | 7.57% |
| Betterware de Mexico SAPI de C | 8.08% | 70.20% | 10.82% |
Volatility & Risk
Niagen Bioscience has a beta of 2.12, indicating that its share price is 112% more volatile than the S&P 500. Comparatively, Betterware de Mexico SAPI de C has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500.
Summary
Niagen Bioscience beats Betterware de Mexico SAPI de C on 9 of the 14 factors compared between the two stocks.
About Niagen Bioscience
Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.
About Betterware de Mexico SAPI de C
Betterware de Mexico, S.A.B. de C.V. operates as a direct-to-consumer company in Mexico. The company focuses on the home organization segment with a product portfolio, including home solutions, kitchen and food preservation, technology and mobility, and other categories. It serves approximately 3 million households through distributors and associates in approximately 800 communities throughout Mexico. The company was formerly known as Betterware de México, S.A.P.I. de C.V. Betterware de Mexico, S.A.B. de C.V. was founded in 1995 and is based in Zapopan, Mexico. Betterware de Mexico, S.A.B. de C.V. is a subsidiary of Campalier, S.A. de C.V.
Receive News & Ratings for Niagen Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Niagen Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
